Several clinical and experimental studies have established that constitutive activation of the phosphatidylinositol 3′-OH kinase (PI3K)-Akt pathway is an essential step towards initiation and maintenance of various human malignancies, including prostate cancer [6,7,8]. Here, AKT1 is linked to prostate carcinoma.